Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
The Journal of Biological Chemistry
|
December 14, 2011
The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation
Jennie Lugassy, Shelly Zaffryar-Eilot, Sharon Soueid, et al.
The Journal of Biological Chemistry
|
June 16, 2007
Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis
Noga Guttmann-Raviv, Niva Shraga-Heled, Asya Varshavsky, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 4, 2016
The semaphorins and their receptors as modulators of tumor progression
Gera Neufeld, Yelena Mumblat, Tanya Smolkin, et al.
Plos One
|
December 31, 2016
A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization
Shira Toledano, Huayi Lu, Agustina Palacio, et al.
Cancer Research
|
September 19, 2012
Neuropilin-1-dependent regulation of EGF-receptor signaling
Sabrina Rizzolio, Noa Rabinowicz, Elena Rainero, et al.
Frontiers in Immunology
|
April 20, 2018
Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis
Jacob Bejar, Ofra Kessler, Adi D Sabag, et al.
Journal of Cell Science
|
October 23, 2014
The role of the plexin-A2 receptor in Sema3A and Sema3B signal transduction
Adi D Sabag, Tatyana Smolkin, Yelena Mumblat, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 31, 2010
Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2
Vera Brekhman, Jennie Lugassie, Shelly Zaffryar-Eilot, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 4, 2006
Functional interaction of VEGF-C and VEGF-D with neuropilin receptors
Terhi Kärpänen, Caroline A Heckman, Salla Keskitalo, et al.
Cancer Research
|
February 12, 2004
Semaphorin-3F is an inhibitor of tumor angiogenesis
Ofra Kessler, Niva Shraga-Heled, Tali Lange, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
The Journal of Biological Chemistry
|
December 14, 2011
The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation
Jennie Lugassy, Shelly Zaffryar-Eilot, Sharon Soueid, et al.
The Journal of Biological Chemistry
|
June 16, 2007
Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis
Noga Guttmann-Raviv, Niva Shraga-Heled, Asya Varshavsky, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 4, 2016
The semaphorins and their receptors as modulators of tumor progression
Gera Neufeld, Yelena Mumblat, Tanya Smolkin, et al.
Plos One
|
December 31, 2016
A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization
Shira Toledano, Huayi Lu, Agustina Palacio, et al.
Cancer Research
|
September 19, 2012
Neuropilin-1-dependent regulation of EGF-receptor signaling
Sabrina Rizzolio, Noa Rabinowicz, Elena Rainero, et al.
Frontiers in Immunology
|
April 20, 2018
Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis
Jacob Bejar, Ofra Kessler, Adi D Sabag, et al.
Journal of Cell Science
|
October 23, 2014
The role of the plexin-A2 receptor in Sema3A and Sema3B signal transduction
Adi D Sabag, Tatyana Smolkin, Yelena Mumblat, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 31, 2010
Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2
Vera Brekhman, Jennie Lugassie, Shelly Zaffryar-Eilot, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 4, 2006
Functional interaction of VEGF-C and VEGF-D with neuropilin receptors
Terhi Kärpänen, Caroline A Heckman, Salla Keskitalo, et al.
Cancer Research
|
February 12, 2004
Semaphorin-3F is an inhibitor of tumor angiogenesis
Ofra Kessler, Niva Shraga-Heled, Tali Lange, et al.
Page
of 7